Free Trial

2seventy bio (TSVT) Stock Forecast & Price Target

$4.77
+0.33 (+7.43%)
(As of 07/15/2024 ET)

2seventy bio - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Consensus Price Target

$12.43
160.56% Upside
High Forecast$26.00
Average Forecast$12.43
Low Forecast$2.00
TypeCurrent Forecast
7/16/23 to 7/15/24
1 Month Ago
6/16/23 to 6/15/24
3 Months Ago
4/17/23 to 4/16/24
1 Year Ago
7/16/22 to 7/16/23
Consensus Rating
Moderate Buy
Moderate Buy
Hold
Buy
Strong Buy
1 Strong Buy rating(s)
1 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
4 Buy rating(s)
4 Buy rating(s)
3 Buy rating(s)
5 Buy rating(s)
Hold
4 Hold rating(s)
4 Hold rating(s)
5 Hold rating(s)
0 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$12.43$12.43$13.17$29.00
Forecasted Upside160.56% Upside137.50% Upside148.04% Upside139.24% Upside
Get 2seventy bio Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for TSVT and its competitors with MarketBeat's FREE daily newsletter.

TSVT Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

TSVT Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

2seventy bio Stock vs. The Competition

Type2seventy bioMedical CompaniesS&P 500
Consensus Rating Score
2.50
2.71
2.50
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside160.56% Upside996.93% Upside9.41% Upside
News Sentiment RatingPositive News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
6/27/2024Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingNeutral ➝ Neutral$5.00 ➝ $5.00+28.53%
6/6/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeNeutral ➝ Sell$5.00 ➝ $2.00-56.14%
5/9/2024Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Newman
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
4/8/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$9.00 ➝ $12.00+117.79%
1/31/2024Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
D. Graybosch
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeMarket Perform ➝ Outperform
1/31/2024TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Market Perform
1/31/2024SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeMarket Perform ➝ Outperform$5.00 ➝ $18.00+348.88%
9/12/2023Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Neutral
7/28/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOverweight ➝ Equal Weight$25.00 ➝ $13.00+58.73%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 10:35 PM ET.

TSVT Forecast - Frequently Asked Questions

What is 2seventy bio's forecast for 2024?

According to the research reports of 10 Wall Street equities research analysts, the average twelve-month stock price forecast for 2seventy bio is $12.43, with a high forecast of $26.00 and a low forecast of $2.00.

Should I buy or sell 2seventy bio stock right now?

10 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for 2seventy bio in the last year. There is currently 1 sell rating, 4 hold ratings, 4 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" TSVT shares.

Does 2seventy bio's stock price have much upside?

According to analysts, 2seventy bio's stock has a predicted upside of 140.47% based on their 12-month stock forecasts.

Has 2seventy bio been upgraded or downgraded by Wall Street analysts recently?

Over the previous 90 days, 2seventy bio's stock had 1 upgrade and 1 downgrade by analysts.

What analysts cover 2seventy bio?

2seventy bio has been rated by research analysts at Canaccord Genuity Group, Canaccord Genuity Group, The Goldman Sachs Group, and Wedbush in the past 90 days.

Do Wall Street analysts like 2seventy bio more than its competitors?

Analysts like 2seventy bio less than other "medical" companies. The consensus rating score for 2seventy bio is 2.50 while the average consensus rating score for "medical" companies is 2.71. Learn more on how TSVT compares to other companies.


This page (NASDAQ:TSVT) was last updated on 7/15/2024 by MarketBeat.com Staff

From Our Partners